Many heart, kidney, and metabolic conditions don't come with warning signs. By the time symptoms appear, it may already be too late.
In Malaysia, millions are living with ๐ฐ๐ฎ๐ฟ๐ฑ๐ถ๐ผ-๐ฟ๐ฒ๐ป๐ฎ๐น-๐บ๐ฒ๐๐ฎ๐ฏ๐ผ๐น๐ถ๐ฐ (๐๐ฅ๐ ) conditions without knowing it. That's why early screening matters.
Today, together with Boehringer Ingelheim under the Sihat Sama-Sama initiative, we are proud to launch ๐๐ฎ๐ด๐ฎ ๐๐ฎ๐ฟ๐๐ถ๐ฎ ๐ฎ.๐ฌ, helping more Malaysians detect risks earlier and take action before complications arise.
Building on the success of Jaga CarDia 1.0, ๐๐ฒ ๐ฎ๐ฟ๐ฒ ๐ฒ๐ ๐ฝ๐ฎ๐ป๐ฑ๐ถ๐ป๐ด ๐ฎ๐ฐ๐ฐ๐ฒ๐๐ ๐๐ผ ๐ญ๐ฌ,๐ฑ๐ฌ๐ฌ ๐๐๐ฏ๐๐ถ๐ฑ๐ถ๐๐ฒ๐ฑ ๐ฏ๐น๐ผ๐ผ๐ฑ ๐๐ฐ๐ฟ๐ฒ๐ฒ๐ป๐ถ๐ป๐ด๐, supported by a dedicated Cardio-Renal-Metabolic (CRM) microsite and teleconsultation services to make screening, guidance, and follow-up care more accessible than ever.
The launch also featured an insightful panel discussion, "๐ข๐ป๐ฒ ๐๐ฒ๐ฎ๐น๐๐ต ๐ฆ๐๐๐๐ฒ๐บ, ๐ ๐ฎ๐ป๐ ๐ฅ๐ผ๐น๐ฒ๐: ๐ ๐ฎ๐ป๐ฎ๐ด๐ถ๐ป๐ด ๐๐ฒ๐ฎ๐ฟ๐, ๐๐ถ๐ฑ๐ป๐ฒ๐ ๐ฎ๐ป๐ฑ ๐ ๐ฒ๐๐ฎ๐ฏ๐ผ๐น๐ถ๐ฐ ๐ฅ๐ถ๐๐ธ ๐ง๐ผ๐ด๐ฒ๐๐ต๐ฒ๐ฟ," bringing together perspectives from a nephrologist, pharmacist, telehealth doctor, and a CRM patient. The session highlighted the importance of multidisciplinary care, patient empowerment, and early intervention in improving long-term health outcomes. ๐๐ฒ๐๐๐ฒ๐ฟ ๐ต๐ฒ๐ฎ๐น๐๐ต ๐ผ๐๐๐ฐ๐ผ๐บ๐ฒ๐ ๐ฎ๐ฟ๐ฒ ๐ฝ๐ผ๐๐๐ถ๐ฏ๐น๐ฒ ๐๐ต๐ฒ๐ป ๐ฒ๐๐ฒ๐ฟ๐๐ผ๐ป๐ฒ ๐ฝ๐น๐ฎ๐๐ ๐ฎ ๐ฝ๐ฎ๐ฟ๐.
A special thank you to Boehringer Ingelheim for bringing an ๐ถ๐บ๐บ๐ฒ๐ฟ๐๐ถ๐๐ฒ ๐ฉ๐ฅ ๐ฒ๐ ๐ฝ๐ฒ๐ฟ๐ถ๐ฒ๐ป๐ฐ๐ฒ to today's launch event. We were honoured to be among the first to experience this innovative journey, offering a deeper understanding of the impact of cardio-renal-metabolic conditions and the importance of early intervention.
